Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Of Recurrent Central Nervous System Primitive Neuroectodermal Tumors (PNETs) In Children And Adolescents A Strategy Including The Use Of High Dose Thiotepa And High Dose Carboplatin

NCT00025077 is registered in ClinicalTrials.gov with Children's Cancer and Leukaemia Group as lead sponsor.

NCT NCT00025077
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00025077 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Of Recurrent Central Nervous System Primitive Neuroectodermal Tumors (PNETs) In Children And Adolescents A Strategy Including The Use Of High Dose Thiotepa And High Dose Carboplatin
Lead sponsor
Children's Cancer and Leukaemia Group
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2000
Completion date
April 30, 2011
Enrollment
50 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors